ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,156 | -11.1% | 27,170 | +0.7% | 0.00% | – |
Q2 2023 | $62,059 | -15.4% | 26,982 | +11.4% | 0.00% | – |
Q1 2023 | $73,384 | +14.3% | 24,219 | -12.1% | 0.00% | – |
Q4 2022 | $64,210 | +36.6% | 27,558 | +12.4% | 0.00% | – |
Q3 2022 | $47,000 | -26.6% | 24,515 | +3.4% | 0.00% | – |
Q2 2022 | $64,000 | -31.2% | 23,713 | -23.7% | 0.00% | – |
Q1 2022 | $93,000 | -34.5% | 31,080 | -15.1% | 0.00% | – |
Q4 2021 | $142,000 | +5.2% | 36,599 | +16.3% | 0.00% | – |
Q3 2021 | $135,000 | +18.4% | 31,477 | -16.2% | 0.00% | – |
Q2 2021 | $114,000 | +192.3% | 37,580 | +219.8% | 0.00% | – |
Q1 2021 | $39,000 | -17.0% | 11,750 | -10.3% | 0.00% | – |
Q4 2020 | $47,000 | +104.3% | 13,104 | -14.9% | 0.00% | – |
Q3 2019 | $23,000 | -45.2% | 15,394 | -24.3% | 0.00% | – |
Q2 2019 | $42,000 | -48.1% | 20,342 | -10.3% | 0.00% | – |
Q1 2019 | $81,000 | -5.8% | 22,682 | +0.7% | 0.00% | -100.0% |
Q4 2018 | $86,000 | -66.1% | 22,521 | -16.3% | 0.00% | -50.0% |
Q3 2018 | $254,000 | +25.1% | 26,911 | -3.3% | 0.00% | +100.0% |
Q2 2018 | $203,000 | +59.8% | 27,835 | +9.4% | 0.00% | 0.0% |
Q1 2018 | $127,000 | -15.3% | 25,453 | -14.2% | 0.00% | 0.0% |
Q4 2017 | $150,000 | – | 29,660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |